IMO Health
IMO Health maintains a clinical vocabulary and knowledge graph, built by clinicians, that links the language doctors use to concepts, standard codes and their relationships, and it pushes more than 250,000 terminology updates a year. Epic, Oracle Health and MEDITECH carry IMO terminology inside their records, and athenahealth, eClinicalWorks, NextGen Healthcare and other ambulatory vendors have long relationships with it.
On that base IMO sells AI for data work. IMO Clinical AI extracts problems, procedures, medications and other findings from narrative notes, Precision Normalize maps structured and unstructured data to standard vocabularies with a confidence score for each match, and Precision Sets manages value sets for analytics and reporting. IMO Core and its Procedure and Periop versions help clinicians build clean problem lists and code diagnoses and procedures in the terms they use, and IMO Studio packages the workflow products. A developer platform offers APIs for the knowledge graph, extraction and removal of identifiers from text, and since November 2026 the knowledge graph is available inside Google Cloud's Gemini for healthcare.
Customers include Cedars-Sinai, MetroHealth, McLeod Health, Nationwide Children's, Piedmont Healthcare, Ozarks Healthcare and the CyncHealth exchange, and Abridge uses the knowledge graph as a reference layer. IMO reports figures such as 84% of codes applied without human intervention and 68% fewer denials from laterality coding. Founded in 1994 as Intelligent Medical Objects and based in Rosemont, Illinois, it acquired Melax Tech in 2023 and sells enterprise licenses by sales order.
Capability Axes
An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read
Learned models drive the data transformation products. IMO Clinical AI uses natural language processing to pull clinical findings out of narrative text, and Precision Normalize combines AI with the curated terminology to standardize records full of incompatible language and codes, which is where the denial, coding and chart review savings are claimed.
Much of the company's value predates those models. The terminology inside Epic, Oracle Health and MEDITECH, exact code crosswalks in the knowledge graph and the IMO Core problem list tools deliver maintained clinical content through lookup rather than inference, and Google's Gemini for healthcare uses the graph precisely as a deterministic source.
Normalization returns candidate matches with a confidence score for each term, so a customer can route low confidence matches to review and let high confidence ones flow automatically; IMO reports 84% of codes applied without intervention. In IMO Core, clinicians review a proposed cleanup of the problem list and choose which changes to accept, and the subscription terms reserve medical and coding decisions for the customer.
Extraction can run unattended when a customer application calls it, and the customer controls what enters its own systems. The same review interface and escalation controls are not described across every API and partner deployment.
A deep learning environment, rules and an openly accessible vocabulary make up IMO Clinical AI, and the developer documentation lists what each pipeline extracts, from coded problems to procedures, with the scores and fields it returns. IMO also describes retrieval augmented generation built over its terminology, while exact crosswalks in the knowledge graph run on a separate deterministic mechanism, which is how Google's Gemini for healthcare presents it.
Inputs, coded outputs and review options are documented. Model architecture by release and the data and procedures used to train the extraction models are not disclosed.
IMO Health develops and tunes its own clinical language models and brought in Melax Tech's biomedical language processing technology through acquisition, with pipelines resting on vocabulary and mappings maintained by its terminology team. The Gemini for healthcare arrangement exposes the knowledge graph to applications built on Google's platform, which makes Google a channel for IMO content rather than the engine behind IMO's extraction APIs. Customers can also host the development toolkit in named clouds.
No base model, provider and version is given for every generative and extraction pipeline, and no full dependency inventory is published.
In a coding experiment, IMO reported 92% accuracy on primary and secondary ICD-10-CM codes when language models were combined with its knowledge layer, against 55% for the strongest unmodified model on the same dataset, with no sample size given. The homepage reports 98% for the same code types in its data standardization offering, alongside 92% fewer manual data quality tasks. CyncHealth describes standardizing exchange data with Precision Normalize, and at Ozarks Healthcare 88 of 90 clinicians took up an IMO Core problem list view.
The adoption figure measures workflow uptake rather than accuracy, and a Manchester study used IMO terms inside another system rather than validating the current AI service.
Data is encrypted in transit and at rest, access to protected health information is limited and access logs are monitored. Developers can run an entity detection pipeline that finds identifiers in clinical text and apply a policy that decides how each type is masked, and the subscription agreement forbids processing protected health information without the applicable signed agreement. Trial access and paid clinical implementations are separate arrangements.
Whether uploaded notes or user feedback can be used to improve models, and how customers set retention and deletion for particular APIs or downstream partners, are described only at a general level.
The subscription agreement requires an executed business associate agreement, data protection agreement or other required instrument before any licensed solution handles protected health information. IMO says its own third parties with access to that information must sign business associate agreements, and its trust center shows an independent HIPAA controls assessment by EisnerAmper.
The agreement itself is not in the public contract, and no table shows which APIs, production accounts or support arrangements may process protected health information, so a developer moving from the trial environment to production learns the terms in negotiation.
A public trust center carries the security material, including a SOC 2 Type II audit claim and a HIPAA page that names EisnerAmper as the independent assessor, gives an assessment date and lists the categories of mapped controls. The product FAQ adds encryption, access monitoring and oversight of the third parties that touch protected data, so a buyer can see who audited what before a security review starts.
The full current SOC 2 report, its system boundaries, testing period and any exceptions that bear on individual Clinical AI endpoints are not public and would come through the trust center's request process.
The subscription agreement describes the licensed solutions as information management tools that need trained professional involvement, and excludes diagnosis and prescription. The products recognize clinical terms, map data to standard vocabularies and surface documentation or coding suggestions, with clinicians and coders responsible for how they are used.
IMO also says partners can build its terminology and clinical APIs into clinical decision support products, and those uses carry no authorization from IMO's own APIs. No FDA clearance or statutory exclusion analysis is given for the extraction and normalization services themselves, including the clinical trial matching and risk adjustment uses it markets.
Clinical terminologists and language processing specialists build and evaluate the pipelines, and the developer toolkit supports collaborative annotation, quality assurance and performance measurement for trained models. Confidence scores on every normalized term give customers a way to review model output before using it, and the subscription terms promise advance notice before changes that break documented functions, except in emergencies.
No fairness results are reported across patient groups, documentation styles or languages for extraction and normalization, and no independent audit of model level bias is described. For a vocabulary carried inside Epic, Oracle Health and MEDITECH, those gaps reach far downstream.
The licensed solutions agreement promises repair or replacement when a purchased service has a material error against its documentation, and if IMO cannot fix the covered problem within 30 days the customer can terminate and receive a prorated refund of unused prepaid fees. That gives a customer a defined exit with money back when the software does not perform as documented.
The same agreement disclaims any warranty on the completeness or accuracy of coding suggestions and leaves coding decisions to the user, and trial services carry no performance warranty. So the remedy covers a failure of documented function, not a wrong code or a missed finding from a model.
Epic, Oracle Health and MEDITECH run IMO terminology inside their records, athenahealth, eClinicalWorks, NextGen Healthcare and other ambulatory vendors have long relationships with it, and Redox is a named partner. IMO Studio supports Epic customers, McLeod Health uses IMO for CPT mapping in Epic, and the developer portal provides APIs for coded entities, FHIR compatible terminology and extraction from notes. Ozarks Healthcare uses IMO Core inside its existing chart workflow, and CyncHealth normalizes records arriving from many systems.
No public case traces IMO Clinical AI both reading from a chart and writing results back in the same named installation.
IMO Studio and the clinical APIs are hosted, while the natural language processing development toolkit can run locally or in Amazon Web Services, Google Cloud or Microsoft Azure, as well as in software as a service form with several exchange formats. API customers can start in an evaluation environment before a licensed production setup, and the knowledge graph is now also reachable through Google Cloud's Gemini for healthcare.
Running the toolkit locally gives a customer control over location. For each hosted clinical API, no standard region, transfer route or backup location is given, and whether every managed offering can be hosted by the customer is not stated.
Enterprise customers license selected solutions through a sales order and buy services through a statement of work. The terms describe subscription charges, annual changes and possible charges for higher usage or added modules, and the developer portal offers a trial of selected APIs. IMO also publishes revenue and coding accuracy calculators for prospects to estimate value.
No price or charging unit is published for any licensed clinical AI service. The separate IMO Anywhere reference subscription has its own terms, which do not set fees for extraction, normalization or a wider IMO Studio subscription.
Users run from hospital clinicians documenting diagnoses and reconciling problem lists to health information exchanges standardizing codes, analysts building research cohorts, payers working risk adjustment and life sciences teams screening trial candidates or reviewing literature. Ozarks Healthcare uses the problem list product in acute care and specialist workflows, CyncHealth uses normalization across its exchange, Nationwide Children's and Cedars-Sinai appear as customers, and IMO Core Periop covers surgical scheduling and documentation.
The developer catalog spans diagnoses, procedures, medications and lab results, and the vocabularies and datasets each pipeline supports vary by endpoint.
Alternatives to IMO Health
Other products that do the same kind of work as IMO Health, and what each one does.
Clinical knowledge management and quality improvement platform anchored in anesthesiology and perioperative services, built on the premise that the gap is less missing evidence than the distance between documented protocol and actual practice.
Truveta is owned by 30 US health systems that contribute de-identified health records every day to a shared research dataset.
Avo is a clinician built decision support platform whose foundation is content rather than a model.
Glass Health is a clinical intelligence platform whose reasoning engine is the product.
Ember AI is an AI revenue integrity platform for specialty physician practices, surgery centers and health systems, sold on preventing denials upstream and recovering them downstream.
Autonomize AI, founded in Austin in 2022, sells the Autonomize Intelligence Platform for healthcare operations, with health plans as its main buyer and provider organizations and life sciences companies alongside.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Custom enterprise subscription
|
Licensed solutions and service charges are set by sales order or statement of work, and the subscription terms allow charges tied to usage. No recurring rate or usage unit is published. | Processing protected health information requires the applicable signed agreement, such as a business associate agreement. Which plans qualify, and any fee, are set in the order. | The subscription terms contemplate implementation fees, but charges and covered services are set in the applicable order or statement of work. | Vendor Published |
Some developer interfaces offer an evaluation environment. Production access, subscription limits and renewal terms depend on the licensed solutions in the order.